Verizon Wireless, one of the leading telecommunication company in the U.S., has recently revealed the expansion its 5G internet network at parts of New Hampture and Ohio. This is a significant addition to the company’s previous plan t....
HIV AIDS cases have been prevailing and increasingly growing across the world. Currently, about 37.9 million people are suffering from HIV globally. Several global pharmaceutical firms are increasingly working and investing heavily in R&....
Tele Greenland, a renowned Nuuk based telecommunications company, has reportedly stated that it will be choosing Ericsson over Huawei to supply its future fifth generation 5G telecoms network equipment. The decision comes after the Preside....
Seattle Genetics, Inc., a biotechnology company based in U.S., and Astellas Pharma Inc. have recently revealed that the U.S. Food and Drug Administration (FDA) has given PADCEV™ an accelerated approval for treating adult patients with....
The deal is anticipated to close in the third quarter of 2020, subject to relevant regulatory approvals and other customary closing terms. Cigna has reportedly announced that it has entered into an agreement with New York Life Insurance fo....
TransThera will initiate a Phase 1 clinical trial for TT-00920 in early 2020 TT-00920 is believed to be a new transformative treatment for chronic heart failure TransThera Biosciences Co. Ltd, a China-based clinical-stage biote....
The optical sensors are designed to integrate into Union Medical’s Neo Thermos Neo Thermos is utilized to treat tumors without affecting the normal cells Photon Control Inc., a developer and supplier of optical measuremen....
Myriad Genetics, Inc., a company focused on precision medicine and molecular diagnostics, has reportedly presented the result of a new validation study of its polygenic risk score (PRS) for breast cancer at the 2019 San Antonio Breast Cance....
The genomics company announced the launch of Targeted Locus Amplification (TLA) technology for complete cancer gene mutation sequencing. TLA sequencing of lymphoma cancer exhibited appreciable improvement over FISH, as depicted ....
ProQR Therapeutics NV, a renowned Dutch biopharmaceutical company dedicated on finding treatments for rare genetic diseases, has reportedly announced the dosage of first patient in Phase 1/2 Aurora study of QR-1123. For the record, QR-1123....
© 2024 ReportsGO.com. All Rights Reserved.